Clinical Trial Update: Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid [Phase 3]

View source ↗

Summary

Phase 3 trial update for fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Gliolan (5-aminolevulinic acid)

Snippet

Sponsor: medac GmbH | Conditions: Brain Cancer, Brain Tumors | Phase 3 | Status: COMPLETED